Premier technology investment conference to showcase the Southeast’s most promising technology companies
Press Release – updated: Sep 27, 2017 12:01 EDT
ATLANTA, September 27, 2017 (Newswire.com) – MMJ Labs, makers of Buzzy® and VibraCool®, announced today that they have been selected to present at Venture Atlanta 2017, the Southeast’s premier event for connecting technology innovation and investment capital. The 10th annual Venture Atlanta will be held Oct. 11-12 at the College Football Hall of Fame in Atlanta and will feature close to 150 funds from across the country. With more than 900 investors, tech entrepreneurs and executives anticipated to be in attendance, this year’s Venture Atlanta is once again lining up to be a sold-out event.
“Our VibraCool device is helping people avoid opioids. Apart from seeking funding for Buzzy on Shark Tank, we have bootstrapped and grown slowly. Now, we’re excited to raise funds to scale to wider distribution,” said CEO and Founder Amy Baxter MD. “Venture Atlanta is an amazing opportunity to find partners for our clinically-proven, revolutionary pain relief products.”
MMJ Labs was chosen as one of 35 companies from a large pool of applicants that represent the region’s most innovative tech businesses. Buzzy®, the flagship product of MMJ Labs, is already adopted widely in hospitals and clinics, and the company holds multiple patents on its FDA-Cleared CoolPulse™ technology.
Venture Atlanta is an amazing opportunity to find partners for our clinically-proven, revolutionary pain relief products.
Adding to the Venture Atlanta excitement are Mark Cuban, chairman and CEO of AXS TV and one of the “sharks” on ABC’s hit show, Shark Tank, and Ernie Garcia, CEO of Carvana, who will deliver keynote presentations.
“Through the years, Venture Atlanta has earned a reputation for consistently identifying tomorrow’s cutting-edge technologies while helping to launch over 380 companies and secure over $2 billion in funding,” said Allyson Eman, executive director of Venture Atlanta. “This year’s event marks our 10th anniversary and includes the strongest and largest roster yet of both early and venture-stage companies — showcasing the depth, breadth and opportunity within the region’s technology community.”
During the two-day event, presenting companies and conference attendees will engage with regional as well as national venture capitalists, investors and other key players in the current technology ecosystem. The conference results in funding, national investor exposure, invaluable relationship building and mentoring by successful technology executives. The conference will also, for the first time, include 16 Startup Showcase companies that will share their plans and vision for the future as “companies to watch.”
To learn more about MMJ Labs, visit MMJLabs.com. For additional information about Venture Atlanta, to register for the event or to view the conference schedule, please visit www.ventureatlanta.org.
About Venture Atlanta
Venture Atlanta, Georgia’s technology innovation event, is where the region’s most promising tech companies meet the country’s top-tier investors. As the South’s largest investor showcase helping launch more than 380 companies and raise over $2 billion in funding to date, Venture Atlanta connects local entrepreneurs with local and national venture capitalists, bankers, angel investors and others in the technology ecosystem who can help them raise the capital they need to grow their businesses. The annual nonprofit event is a collaboration of three leading Georgia business organizations: Atlanta CEO Council, Metro Atlanta Chamber and the Technology Association of Georgia (TAG). For more information, visit www.ventureatlanta.org. For updates, join us on LinkedIn, follow us on Twitter, and visit our blog.
About MMJ Labs
MMJ Labs was established in 2006 by Dr. Amy Baxter, a pediatrician and pain researcher, to develop reusable, inexpensive products for personal pain control. The initial product launched was Buzzy®, a bee-shaped palm-sized device combining cold and vibration. When placed between the brain and the pain, the competing stimulus controls or inhibits sharp pain. Additional products include DistrACTION® cards which reduce pain through distraction, and VibraCool(r) Sport Therapy.
Since the official product launch May 1, 2009, Buzzy® has been adopted by over 5000 hospitals and clinics worldwide, and by consumers for IVF, arthritis injections, and non-needle procedures. MMJ Labs’ awards include the prestigious Medical Design Excellence Award, Small Business Blue Ribbon award from the US Chamber of Commerce 2015, Top Ten Innovation Companies in Georgia, Georgia RockStars of Entrepreneurship, and the Georgia GLOBE award for international business development and exporting.
Buzzy® is reusable and proudly made in the USA.
Source: MMJ Labs
Powered by WPeMatico